Hospital Transmission of Community-Acquired Methicillin-Resistant Staphylococcus aureus among Postpartum Women

Clinical Infectious Diseases

Volumn 37, Issue 10, 2003, Pages 1313-1319

  Saiman, Lisa ^a,b   O'Keefe, Mary ^a   Graham III, Philip L ^a   Wu, Fann ^a   Saïd Salim, Battouli ^c   Kreiswirth, Barry ^c   LaSala, Anita ^b   Schlievert, Patrick M ^d   Della Latta, Phyllis ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCIDIN; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN C; STAPHYLOCOCCUS ENTEROTOXIN H; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BREAST ABSCESS; CELLULITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE CASSETTE; HOSPITAL; HOSPITAL INFECTION; HUMAN; MASTITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PUERPERAL INFECTION; PULSED FIELD GEL ELECTROPHORESIS; PUSTULOSIS; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; POSTPARTUM PERIOD; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 0242468557     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379022     Document Type: Article

References (43)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
2. Maguire GP, Arthur AD, Boustead PJ, et al. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 1996; 164:721-3.
3. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 1999; 282:1123-5.
4. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593-8.
5. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999; 29:797-800.
6. Abi-Hanna P, Frank AL, Quinn JP, et al. Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis 2000; 30:630-1.
7. Hussain FM, Boyle-Vavra S, Bethel CD, et al. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 2000; 19:1163-6.
8. Frank AL, Marcinak JF, Mangat PD, et al. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999; 18:993-1000.
9. Frank AL, Marcinak JF, Mangat PD, et al. Increase in community-acquired methicillin-resistant Staphylococcus aureus in children. Clin Infect Dis 1999; 29:935-6.
10. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin- resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35:819-24.
11. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-32.
12. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753-9.
13. Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002; 46:1147-52.
14. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359:1819-27.
15. Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186: 1344-7.
16. Nimmo GR, Schooneveldt J, O'Kane G, et al. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J Clin Microbiol 2000; 38:3926-31.
17. Jarvis WR. The epidemiology of colonization. Infect Control Hosp Epidemiol 1996; 17:47-52.
18. Roberts RB, de Lencastre A, Eisner W, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study Group. J Infect Dis 1998; 178:164-71.
19. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
20. Shopsin B, Gomez M, Montgomery SO, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37:3556-63.
21. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:2155-61.
22. Fey PD, Said-Salim B, Rupp ME, et al. Comparative molecular analysis of community-or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:196-203.
23. Monday SR, Bohach GA. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J Clin Microbiol 1999; 37:3411-4.
24. Schlievert PM. Immunochemical assays for toxic shock syndrome toxin-1. Methods Enzymol 1988; 165:339-44.
25. Blomster-Hautamaa DA, Schlievert PM. Preparation of toxic shock syndrome toxin-1. Methods Enzymol 1988; 165:37-43.
26. Noda M, Kato I. Purification and crystallization of staphylococcal leukocidin. Methods Enzymol 1988; 165:22-32.
27. Saiman L, Cronquist A, Wu F, et al. Outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003; 24:317-21.
28. Morel AS, Wu F, Della-Latta P, et al. Nosocomial transmission of methicillin-resistant Staphylococcus aureus from a mother to her preterm quadruplet infants. Am J Infect Control 2002; 30:170-3.
29. Devereux WP. Acute puerperal mastitis: evaluation of its management. Am J Obstet Gynecol 1970; 108:78-81.
30. Marshall BR, Hepper JK, Zirbel CC. Sporadic puerperal mastitis: an infection that need not interrupt lactation. JAMA 1975; 233:1377-9.
31. Marchant DJ. Inflammation of the breast. Obstet Gynecol Clin North Am 2002; 29:89-102.
32. Matheson I, Aursnes I, Horgen M, et al. Bacteriological findings and clinical symptoms in relation to clinical outcome in puerperal mastitis. Acta Obstet Gynecol Scand 1988; 67:723-6.
33. Kalstone C. Methicillin-resistant staphylococcal mastitis. Am J Obstet Gynecol 1989; 161:120.
34. Gibberd GF. Sporadic and epidemic puerperal breast infections: a contrast in morbid anatomy and clinical signs. Am J Obstet Gynecol 1953; 65:1038-41.
35. Ren K, Bannan JD, Pancholi V, et al. Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med 1994; 180: 1675-83.
36. Schlievert PM. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1986; 1:1149-50.
37. Le Thomas I, Mariani-Kurkdjian P, Collignon A, et al. Breast milk transmission of a Panton-Valentine leukocidin-producing Staphylococcus aureus strain causing infantile pneumonia. J Clin Microbiol 2001; 39:728-9.
38. L'Heriteau F, Lucet JC, Scanvic A, et al. Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission. JAMA 1999; 282:1038-9.
39. Gross-Schulman S, Dassey D, Mascola L, et al. Community-acquired methicillin-resistant Staphylococcus aureus. JAMA 1998; 280:421-2.
40. Shopsin B, Mathema B, Martinez J, et al. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis 2000; 182:359-62.
41. Suggs AH, Maranan MC, Boyle-Vavra S, et al. Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr Infect Dis J 1999; 18:410-4.
42. Adcock PM, Pastor P, Medley F, et al. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998; 178:577-80.
43. Shahin R, Johnson IL, Jamieson F, et al. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Toronto Child Care Center Study Group. Arch Pediatr Adolesc Med 1999; 153:864-8.